Harvey Capital Management Inc Abbott Laboratories Transaction History

Harvey Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$114.02 - $139.04 $5.95 Million - $7.26 Million	-52,195 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $34,659 - $42,438	-300 Reduced 0.57%	52,195 $7.35 Million
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $17,499 - $19,359	-150 Reduced 0.28%	52,495 $6.2 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $23,802 - $28,019	225 Added 0.43%	52,645 $6.1 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $225,298 - $265,436	-2,070 Reduced 3.8%	52,420 $6.28 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $515,550 - $561,802	4,910 Added 9.9%	54,490 $5.97 Million
Q3 2020 Oct 27, 2020	BUY	$91.64 - $111.29 $1.73 Million - $2.1 Million	18,845 Added 61.31%	49,580 $5.4 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $1.05 Million - $1.34 Million	13,665 Added 80.05%	30,735 $2.81 Million
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $1.07 Million - $1.57 Million	17,070 New	17,070 $1.35 Million

3,187

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Harvey Capital Management Inc with notifications on news.